Shareholding disclosure

Pictet Funds LUX

Declared position

5.19%

Threshold

Crossed upwards

Timeline

Published

18.06.2009

Transaction

12.06.2009

Voting rights breakdown

Voting rights acquired5.19%

Voting rights sold0%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TC96H00014

Beneficial owner

Pictet Funds LUX

Declared address

Pictet Funds (LUX), 2449 Luxembourg

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Pictet Funds LUX

Basilea Pharmaceutica AG, Allschwil18.06.2009TC96H00014

Disclosure summary

Pictet Funds LUX disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 18.06.2009, at 5.19% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

5.19%

Voting rights acquired

Voting rights acquired5.19%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Pictet Funds LUX disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 18.06.2009.

Publication date18.06.2009

Transaction date12.06.2009

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerPictet Funds LUX

Declared addressPictet Funds (LUX), 2449 Luxembourg

CategoryCollective investment vehicle

Voting rights acquired5.19%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTC96H00014

Source: SIX Exchange Regulation · Publication date: 18.06.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open